LCN2 and Cognitive impairment: Similarly, treatment with l-α-AA reduced the optogenetic stimulation-induced cognitive impairments (Fig 9A and 9B) as well as the Lcn2 and cytokine mRNA expression levels (Fig 9C) in the ChR2-eYFP group.